Navigation Links
Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
Date:11/1/2012

CONCORD, Mass., Nov. 1, 2012 /PRNewswire/ -- Parios Regenerative Sciences, Inc., a privately held medical device company specializing in the development of biomaterials for skin repair and regeneration, has entered into a comprehensive license agreement with Brown University, licensing exclusive rights to a proprietary organic nanotechnology for use in dermatological applications. The nanotechnology, Oderm™, has clinical relevance in cosmetic skin rejuvenation, dermatological applications, and advanced wound care.

"Our agreement with Brown is a significant milestone for Parios," stated Mark Johanson, President and Chief Executive Officer.  "The Oderm™ technology shows great promise in advancing the field of skin regeneration for both aesthetic and wound care applications. We are committed to the commercial and clinical success of this novel skin care product."

Under the terms of the agreement, Parios has obtained an exclusive license to a platform of intellectual property and technologies co-developed by Dr. Thomas Webster, former associate professor of engineering at Brown.

"We are enthusiastic to have partnered with such an experienced and accomplished team at Parios," said Katherine Gordon, Managing Director of the Brown University Technology Ventures Office, "and look forward to successful development of the product."

The Oderm™ biomaterial consists of organic nanomolecules that self-assemble into structures resembling collagen – a major component of skin. Using these organic structures to replace degenerated or damaged skin encourages the growth of natural tissue. The company's goal is to provide off-the-shelf materials that regenerate healthy and functional tissue and offer a repair that lasts the life of the patient.

About Parios Regenerative Sciences, Inc.

Parios is a privately held company located in Concord, MA focused on the growing market of skin tissue regeneration. The company is developing the Oderm™ product line to compete in the non-invasive skin care market, by offering injectable and topical solutions to stimulate collagen regrowth. Current products are in the preclinical phase of development. With Oderm™ and other advanced biomaterials in the pipeline, Parios offers a modern alternative to existing skin repair therapies.


'/>"/>
SOURCE Parios Regenerative Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
2. QPS Acquires JSW Life Sciences, Largest Independent Contract Research Organization in Austria
3. Pressure BioSciences, Inc. Reports 70% Revenue Growth for Second Consecutive Quarter
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update
5. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
6. Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY
7. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
8. KannaLife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)
9. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
10. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
11. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):